FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

758 letters match. Newest first.

  1. Mark S. Dacey, M.D.

    FDA warns Dr. Mark S. Dacey that a trial subject underwent an optional eye-fluid sampling procedure after twice declining consent.

    High risk
  2. Conceive Fertility Center

    FDA says Conceive Fertility Center in Dallas used incomplete donor screening and testing for reproductive cells.

    High risk
  3. Signature Formulations, LLC

    FDA says Signature Formulations made OTC drugs on shared equipment without adequate controls, risking hormone contamination.

    High risk
  4. Cohance Lifesciences Limited

    Cohance Lifesciences, a finished-drug maker, was cited for inadequate investigations and dirty shared equipment that caused cross-contamination.

    High risk
  5. Eniva USA, Inc.

    FDA warns Eniva USA over manufacturing quality failures for Immune Support and Ashwagandha Gummies.

    Medium
  6. Fulijaya Manufacturing SDN. BHD.

    Fulijaya Manufacturing in Malaysia failed CGMP (drug manufacturing rules) for OTC drugs, with missing lab data, flawed microbial tests, and weak stability data.

    High risk
  7. Center For Immunology Science, LLC

    FDA cites Center for Immunology Science for a clinical trial of heat-killed Mycobacterium smegmatis without an Investigational New Drug application.

    High risk
  8. Germaphobix

    FDA warns Germaphobix that its unapproved HIV dried blood spot self-collection kit is adulterated and misbranded.

    High risk
  9. Prodrome Sciences USA, LLC

    Prodrome Sciences studied its supplement ProdromeNeuro Oil as a dementia drug in 29 people without first filing an IND, FDA says.

    High risk
  10. Genetrace

    FDA warned Genetrace that its HIV dried blood spot self-collection kit is unapproved and misbranded.

    High risk
  11. Genovate

    FDA warns Genovate over selling an unapproved HIV dried-blood-spot self-collection kit without marketing authorization.

    High risk
  12. Winder Laboratories, LLC

    FDA warns Winder Laboratories of adulterated prescription drugs due to cleaning and facility failures.

    High risk
  13. Chemspec Chemicals Private Limited

    FDA warns Indian API maker Chemspec Chemicals over missing batch records and data integrity failures.

    High risk
  14. Purushothaman Damodara Kumaran, M.D. / Senthil Specialty Hospital

    FDA warned Senthil Specialty Hospital and Dr. Purushothaman Damodara Kumaran about missed safety monitoring in a bioequivalence study of an investigational drug.

    High risk
  15. Middle East/Soli's Baking Company, Inc. dba Middle East Baking Co.

    FDA found live insects and rodent droppings throughout Middle East Baking's pita and bagel plant in Burlingame, California.

    High risk
  16. Tower Laboratories Ltd.

    FDA warned Tower Laboratories, an OTC drug maker in Montague, MI, for weak out-of-specification investigations and unproven test methods.

    High risk
  17. Unipack LLC

    FDA says Unipack LLC released suppositories without adequate out-of-specification investigations, complete lab records, and required USP testing.

    High risk
  18. Palamur Biosciences Private Limited

    FDA warns Palamur Biosciences over GLP violations in medical device safety testing and inadequate corrective actions.

    High risk
  19. Atomix LLC

    FDA warned Atomix LLC that its website sells unapproved SARM drugs MK-2866 and RAD-140 as new drugs without approval.

    High risk
  20. SV Labs Corporation

    SV Labs released microbe-contaminated OTC drug products and lacked water, process and quality controls, FDA says.

    High risk
  21. TG Supply LLC d/b/a TransGuy Supply

    FDA warned TransGuy Supply that its breast binders are unregistered, unlisted medical devices.

    Low
  22. Flux Lab Pte. Ltd. d/b/a The Fluxion

    FDA warns Flux Lab/The Fluxion over unregistered, unlisted chest binders marketed as medical devices.

    Medium
  23. Marli Washington Design, LLC

    Marli Washington Design (gc2b) sold breast binders as medical devices without FDA registration or listing for FY2026, making them misbranded.

    Low
  24. FLAVNT Streetwear, LLC

    FDA says FLAVNT Streetwear sold breast binders as medical devices without registering or listing them for fiscal 2026.

    Low
  25. Early to Bed, Inc.

    FDA warned Early to Bed, Inc. that its breast binders are misbranded because the manufacturer was not registered or listed with FDA.

    Low
  26. GenderBender LLC

    GenderBender LLC sells breast binders as medical devices without FDA registration or listing, making them misbranded.

    Low
  27. TomboyX, PBC

    FDA says TomboyX sells breast binders as medical devices without registering or listing them, making them misbranded.

    Medium
  28. Philadelphia 7, Inc d/b/a Passional Boutique

    FDA says Philadelphia 7 sold unregistered, unlisted breast binders, making them misbranded devices.

    Low
  29. TOMSCOUT

    FDA says TOMSCOUT sells breast binders as medical devices without required FDA registration or listing.

    Low
  30. For Them, Inc.

    FDA says For Them, Inc. sells breast binders as unregistered medical devices, making them misbranded.

    Low
  31. ShapeShifter Apparel, LLC

    FDA says ShapeShifter Apparel sold breast binders as unregistered, unlisted medical devices, making them misbranded.

    Low
  32. Trans-Missie B.V.

    FDA says Trans-Missie B.V. sells breast binders as medical devices without registering or listing them with FDA.

    Low
  33. Harbor Marine Product Inc.

    FDA found Listeria bacteria on raw ready-to-eat fish contact surfaces and serious seafood HACCP and importer verification failures at Harbor Marine Product.

    High risk
  34. Catalent Indiana, LLC

    Catalent Indiana's Bloomington plant released sterile vials contaminated with mammalian hair and failed to investigate, FDA says.

    High risk
  35. Celularity, Inc

    FDA warns Celularity that Interfyl is an unapproved new drug and unlicensed biological product marketed for orthopedic and wound uses.

    High risk
  36. DeVere Manufacturing Inc.

    FDA warned DeVere Manufacturing in Janesville, Wisconsin, that its OTC hand sanitizers are adulterated after a June 2025 inspection found CGMP failures.

    High risk
  37. Turbare Manufacturing

    FDA warns outsourcing facility Turbare Manufacturing of Conway, Arkansas, for making sterile drugs under insanitary conditions.

    High risk
  38. VarunKart Group LLC dba Organic Wellnesses

    VarunKart Group sells unapproved Ayurvedic and homeopathic drugs with serious disease claims.

    High risk
  39. Handelnine Global, LLC dba Navafresh

    Navafresh sells unapproved Ayurvedic drugs online, and its Rheumacare Capsules contain about 7,000 times the lead level of concern.

    High risk
  40. Owen Biosciences, Inc.

    Owen Biosciences' over-the-counter benzoyl peroxide acne lotion had over 20 parts per million benzene and lacked release testing.

    High risk
  41. Cdymax India Pharma Private Limited

    FDA warned Cdymax (India) Pharma that its Bangalore API plant had inadequate out-of-specification investigations and unvalidated test methods, making its APIs adulterated.

    High risk
  42. Seema International

    FDA warns Seema International over unclean API equipment, missing stability data, and quality-unit failures after inspection; APIs adulterated.

    High risk
  43. Verdure Sciences, Inc.

    FDA says Verdure Sciences ran a clinical trial of Maplifa without submitting a required IND.

    High risk
  44. Siddha Flower Essences, LLC., dba Siddha Remedies

    FDA cites Siddha Remedies, a maker of children's homeopathic drugs, for untested water and botanicals and microbial contamination.

    High risk
  45. DermaRite Industries, LLC

    DermaRite failed CGMP and sold unapproved, misbranded OTC topical drugs, FDA says.

    High risk
  46. Ocho Rios Atlanta Inc.

    Ocho Rios Atlanta lacked required foreign supplier safety plans for imported spices, sauces, juice drinks, and tea, FDA says.

    Medium
  47. Uriel Pharmacy, Inc.

    Uriel Pharmacy's homeopathic ampule drugs are unapproved new drugs and were made under serious CGMP violations.

    High risk
  48. Taizhou Kangping Medical Science and Technology Co., Ltd.

    FDA warns Taizhou Kangping about over-the-counter drugs labeled sterile that were not sterilized.

    High risk
  49. Compass Group USA

    FDA found Listeria in Compass Group's Fresh & Ready Foods plant, tied to an outbreak that sickened ten and killed one.

    High risk
  50. Apotex Inc.

    FDA cited Apotex's Richmond Hill sterile plant for failed investigations and aseptic contamination risks, prompting recalls.

    High risk